Amylin Receptor Agonists

Abstract: The invention relates to a compound comprising an amylin receptor agonist. The invention also relates to a pharmaceutical composition, suitable for but not limited to oral administration, which comprises such a compound. The compound and pharmaceutical composition comprising it may be used for the medical treatment of subjects with overweight, obesity and associated co-morbidities.

Patent Information

Application #

Filing Date

19 July 2025

Publication Number

32/2025

Publication Type

INA

Invention Field

BIOTECHNOLOGY

Status

Email

Parent Application

Applicants

NOVO NORDISK A/S

Novo Alle 1 2880 Bagsværd

Inventors

1. JØRGENSEN, Cecilie Mia

Novo Alle 1 2880 Bagsværd

2. KRUSE, Thomas

Novo Alle 1 2880 Bagsværd

3. LAU, Jesper F.

Novo Alle 1 2880 Bagsværd

Specification

Documents

Application Documents

#	Name	Date
1	202547068966-STATEMENT OF UNDERTAKING (FORM 3) [19-07-2025(online)].pdf	2025-07-19
3	202547068966-Sequence Listing in PDF [19-07-2025(online)].pdf	2025-07-19
4	202547068966-PRIORITY DOCUMENTS [19-07-2025(online)].pdf	2025-07-19
5	202547068966-POWER OF AUTHORITY [19-07-2025(online)].pdf	2025-07-19
6	202547068966-FORM 18 [19-07-2025(online)].pdf	2025-07-19
7	202547068966-FORM 1 [19-07-2025(online)].pdf	2025-07-19
8	202547068966-DECLARATION OF INVENTORSHIP (FORM 5) [19-07-2025(online)].pdf	2025-07-19
9	202547068966-COMPLETE SPECIFICATION [19-07-2025(online)].pdf	2025-07-19